Administration of gemcitabine and cisplatin in cancer patients with renal failure under hemodialysis

There is no optimal dosing schedule of gemcitabine (GEM) and cisplatin (CDDP) combination for cancer patients with renal failure (RF) on hemodialysis (HD). The purpose of this study was to share our experience of using GEM and CDDP in such patients. The starting dose of GEM was defined based on sing...

Ausführliche Beschreibung